| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 3.93% | 24.11% | 40.70% | 47.77% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 24.00% | 18.10% | 16.96% |
| Negative volatility | 13.54% | 10.60% | 10.18% |
| Sharpe | 0.72 | 0.47 | 0.42 |
| Sortino | 1.28 | 0.81 | 0.70 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology N $ | 4.97% | 4.13% | 3.06% | 8.68% | 22.07% | 3.93% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |